Business · 09/09/2015
FDA Reopens Comment Period for Homeopathic Product Regulation, Evaluating 25-Year-Old Framework
The FDA is reopening the comment period for a public hearing notice, allowing interested persons to submit additional comments on the agency's regulatory framework for homeopathic products, which has been in place for nearly a quarter-century.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →